Literature DB >> 8797081

Purification and molecular cloning of calobin, a thrombin-like enzyme from Agkistrodon caliginosus (Korean viper).

B S Hahn1, K Y Yang, E M Park, I M Chang, Y S Kim.   

Abstract

A thrombin-like enzyme, calobin, has been purified to homogeneity from the venom of Agkistrodon caliginosus by a procedure involving Bio-Gel P-100, Mono S, and Pro-RPC. The enzyme was identified as a monomer with a molecular weight of 34,000 on SDS-PAGE, and its isoelectric point was 6.2. Calobin acted on fibrinogen to form fibrin with a specific activity of 226 NIH equivalent units, and also exhibited arginine esterase activity. The enzyme predominantly cleaved the alpha-chain of fibrinogen with little degradation of the beta-chain. It contained abundant asparagine/aspartic acid residues, but very few tyrosine or methionine residues. The proteolytic activity of the enzyme with TAME as a substrate was higher than that of thrombin. However, it showed neither lysine esterase nor caseinolytic activity. The enzyme activity was strongly inhibited by PMSF, and moderately by benzamidine and soybean trypsin inhibitor, indicating it is a serine protease. On the other hand, the enzyme activity was not inhibited by hirudin or aprotinin. cDNA (1.6 kb) for calobin has been cloned from an A. caliginosus cDNA library. The cDNA sequence indicates that calobin is synthesized as a pre-zymogen of 262 amino acids, including a putative secretory signal peptide of 18 amino acids and a proposed zymogen peptide of 6 amino acid residues. The cDNA sequence encodes a 238-amino acid residue molecule exhibiting strong amino acid sequence homology to those of ancrod, batroxobin, and flavoxobin isolated from other snake venoms. Calobin contains 12 cysteine residues. As judged on alignment of the amino acid sequences of other thrombin-like enzymes (batroxobin, ancrod, and flavoxobin), calobin constitute the formation of six disulfide bridges. Amino acid residues, His43, Asp88, and Ser182, which are thought to be the catalytic active site are highly conserved. As calobin is a glycoprotein, its possible glycosylation site, Asn-X-Thr, is located at amino acid residues 81-83.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797081     DOI: 10.1093/oxfordjournals.jbchem.a021319

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Serine protease isoforms of Deinagkistrodon acutus venom: cloning, sequencing and phylogenetic analysis.

Authors:  Y M Wang; S R Wang; I H Tsai
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

2.  Purification, crystallization and preliminary X-ray diffraction analysis of saxthrombin, a thrombin-like enzyme from Gloydius saxatilis venom.

Authors:  Wenqing Wei; Wei Zhao; Xiaoping Wang; Maikun Teng; Liwen Niu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

Review 3.  Molecular evolution of toxin genes in Elapidae snakes.

Authors:  Toru Tamiya; Takahiko J Fujimi
Journal:  Mol Divers       Date:  2006-11-10       Impact factor: 2.943

4.  Isolation and characterization of a serine protease, Ba III-4, from Peruvian Bothrops atrox venom.

Authors:  L A Ponce-Soto; V L Bonfim; J C Novello; R Navarro Oviedo; A Yarlequé Chocas; S Marangoni
Journal:  Protein J       Date:  2007-09       Impact factor: 2.371

5.  Isolation from Gloydius blomhoffii siniticus Venom of a Fibrin(ogen)olytic Enzyme Consisting of Two Heterogenous Polypeptides.

Authors:  Suk-Ho Choi; Seung-Bae Lee
Journal:  J Pharmacopuncture       Date:  2013-06

Review 6.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

7.  Characterization and pharmacological properties of a novel multifunctional Kunitz inhibitor from Erythrina velutina seeds.

Authors:  Richele J A Machado; Norberto K V Monteiro; Ludovico Migliolo; Osmar N Silva; Michele F S Pinto; Adeliana S Oliveira; Octávio L Franco; Sumika Kiyota; Marcelo P Bemquerer; Adriana F Uchoa; Ana H A Morais; Elizeu A Santos
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

8.  Adverse Reactions after Administration of Antivenom in Korea.

Authors:  Jin Seok Shim; Hyunggoo Kang; Yongil Cho; Hyungoo Shin; Heekyung Lee
Journal:  Toxins (Basel)       Date:  2020-08-06       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.